Outcomes4Me
Oncology Clinical Trial Finder
Breast Cancer
Location

Recruiting • Phase NA • Stage 0, I, II, III, IV • ER negative • Post-Menopausal • Interventional

The following is imported from ClinicalTrials.gov:

3-D Super Resolution Ultrasound Microvascular Imaging

This is a 3-arm single center study of 45 patients. These cohorts will include 15 breast patients scheduled to undergo a biopsy, and 15 thyroid patients scheduled to undergo fine needle aspiration, biopsy, or thyroidectomy that consent to undergo an acoustic angiography in conjunction with b-mode ultrasound prior to their scheduled biopsy. Prior to imaging clinical patients, the third arm will include 15 healthy volunteers that will be imaged to optimize imaging parameters.

Increasing the sensitivity and specificity of diagnostic imaging in patients at high risk for breast or thyroid cancer could provide substantial clinical benefit by improving diagnosis, preventing over-treatment, and reducing healthcare costs. Acoustic angiography is a new type of contrast enhanced ultrasound imaging which is specifically sensitive to microvascular structure and density. It evaluates tumor micro-vasculature and may provide a powerful prognostic tool for the diagnosis of breast cancer, and eventually for treatment evaluation.

Breast Cancer

Study Design
Study type:

Interventional

Estimated enrollment:

45 participant

Actual study start date:

May 26, 2022

Eligibility Criteria
Ages eligible for study:

18 - 999

Sexes eligible for study:

both


Arms and Intervention
  • Definity

  • Acoustic Angiography

Trial Information at Site
Last Updated:
Trial Information
ClinicalTrial.gov ID:

Recruiting

Estimated Enrollment:

45

Last Updated:

10/28/2023


Site Contact

Carly Sronce

carly_sronce@med.unc.edu

919-966-3262

Univeristy of North Carolina Chapel Hill

Chapel Hill, North Carolina, United States, 27599


Trial Contact

Carly Sronce

carly_sronce@med.unc.edu

9199663262


Desma Jones, CCRC

desma_jones@med.unc.edu

9198439463


Principal Investigator

Yueh Lee, MD, PhD


Trial Sponsor

UNC Lineberger Comprehensive Cancer Center

Study Location (1)

Univeristy of North Carolina Chapel Hill

Chapel Hill, North Carolina, United States

Outcomes4Me

© 2024 Outcomes4Me Inc. All rights reserved.